- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Piramal Pharma Limited — Important, 03-07-2026: Updates
03-07-2026 | 05:21 pm
03-07-2026 | 05:21 pm
Piramal Pharma's FY26 sustainability report noted a ₹1.15 Cr penalty for environmental compliance and one voluntary Prazosin product recall. The company demonstrated strong ESG performance, utilizing 40.9% renewable energy, achieving 95% waste recovery, and recycling 191,887 kL of water across global sites.
No comments yet. Be the first to comment!